Stay updated on Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the documentation/version history.
    Difference
    0.0%
    Check dated 2026-09-02T19:27:42.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A new funding identifier '2015 ( U.S. NIH Grant/Contract )' was added next to the study identifiers, indicating NIH support for the trial. The addition provides funding context but does not change the study design or eligibility.
    Difference
    0.0%
    Check dated 2026-08-26T19:44:32.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page's revision metadata was updated to version v3.6.5 with August 2026 timestamps, indicating a maintenance update rather than substantive changes to study content.
    Difference
    0.2%
    Check dated 2026-08-12T07:51:17.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page's revision was updated from v3.6.3 to v3.6.4. This appears to be a minor maintenance update that does not change study data or content.
    Difference
    0.0%
    Check dated 2026-07-21T22:44:47.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page now displays a newer revision tag (v3.6.3) replacing the previous v3.6.0, indicating a minor backend/template update without altering study information.
    Difference
    0.0%
    Check dated 2026-06-30T02:56:32.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page now indicates recruitment is closed. It also adds new guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study, and updates the Intervention/Treatment area along with a revision label v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-15T22:22:02.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.